December 8, 2008
Pharmacosmos is pleased to inform that the precautionary recall
has been resolved. New CosmoFer® batches are currently
being supplied to hospitals and healthcare clinics.
About Pharmacosmos A/S
Pharmacosmos develops and markets
medicines for the treatment of iron deficiency. A research-based
company, its ongoing R&D programme focuses on improving the
treatment options for healthcare professionals and patients
suffering from iron deficiency.
Pharmacosmos is a privately-owned
Danish company and operates in more than 50 countries across
Europe, the Americas and Asia. Its facilities are approved by the
Danish Medicines Agency and the US Food & Drug
Administration.